4 I en 24- ugers undersøgelse af sitagliptin 100 mg i kombination med pioglitazon var incidensen af formodede bivirkninger hos de patienter, der blev behandlet med sitagliptin/ pioglitazon sammenlignet med patienterne, der blev behandlet med placebo/ pioglitazon henholdsvis 9, 1% og 9, 0%.
4 In this 24-week study of the combination of sitagliptin 100 mg once daily and pioglitazone, the incidence of adverse reactions considered as drug-related in patients treated with sitagliptin/ pioglitazone compared to patients treated with placebo/ pioglitazone was 9.1% and 9.0%, respectively.